Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Mauricio Salvo"'
Autor:
Claudia Quedenau, Melina Mueller, Mauricio Salvo, Alice Braun, Martin Witzenrath, Toumy Guettouche, Juan Macias Sanchez, Charlotte Thibeault, Dimitri Patriki, Manuel Holtgrewe, Bettina Heidecker, Hans Rudolf Schmid, January Weiner, JM Doehn, Florian Kurth, Jacopo Saccomanno, Benedikt Wiggli, Norbert Suttorp, Victor M. Corman, Wolfgang Poller, Phillip Suwalski, Tatiana Borodina, Terry Jones, Sandra Siemann, Barbara Muehlemann, Ronald K. Binder, Jonas Rutishauser, Elisa T Helbig, Xiaomin Wang, Ralf-Harto Hübner, B. Hinzmann, Anja Blueher, Stefan Hippenstiel, Ulf Landmesser, Dieter Beule, Lena J Lippert, Kathrin Danninger, Hansjuerg Beer, Paula Stubbemann, Zehra Karadeniz, Stjepan Jurisic, Carsten Skurk, Leif E. Sander, Juan A. Pineda, Marta Fernandez-Fuertes, Tomasz Zemojtel, Ulrike Krueger, Luis Miguel Real, Stephan Ripke
BackgroundSince the beginning of the coronavirus disease 2019 (COVID-19) pandemic, there has been increasing demand to identify predictors of severe clinical course in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3d2e7c166d6d529ae509f72207c9dca
https://doi.org/10.1101/2020.12.21.20248121
https://doi.org/10.1101/2020.12.21.20248121
Autor:
Eva Bustamante, Nicolás Miranda-González, Alicia Colombo, Monica Ahumada, María Loreto Bravo, Justo Lorenzo Bermejo, Katherine Marcelain, Ignacio Maureira, Erik Morales, Lorena Gutiérrez, Verónica Sanhueza, Gonzalo de Toro, Jessica Toro, Evelin González-Feliú, Carolina Ibañez, Ricardo A. Verdugo, Ricardo Armisen, Iván Gallegos, Carolina Bizama, M. Loreto Spencer, Patricia García, Mauricio Salvo, Camilo Villamán, Olga Barajas, Ana María Carrasco
Publikováno v:
Journal of Personalized Medicine
Volume 11
Issue 9
Journal of Personalized Medicine, Vol 11, Iss 899, p 899 (2021)
Volume 11
Issue 9
Journal of Personalized Medicine, Vol 11, Iss 899, p 899 (2021)
Next-generation sequencing (NGS) is progressively being used in clinical practice. However, several barriers preclude using this technology for precision oncology in most Latin American countries. To overcome some of these barriers, we have designed